Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03202317
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GI4 | METHYL ACETIC ACID-SUBSTITUTED GLUCOIMIDAZOLE | A,B | 2J7G | 0.79 | |
IIC | 4-IMIDAZOLMETHYLENE-5-IMIDAZOLONE CHROMOPHORE | A | 1BFP | 0.72 | |
DHI | D-HISTIDINE | P | 1MCB | 0.73 | |
DHI | D-HISTIDINE | A | 2EZ7 | 0.73 | |
DHI | D-HISTIDINE | P | 1MCN | 0.73 | |
DHI | D-HISTIDINE | A,D | 1CZQ | 0.73 | |
DHI | D-HISTIDINE | I | 1ER8 | 0.73 | |
DHI | D-HISTIDINE | P | 1MCL | 0.73 | |
DHI | D-HISTIDINE | A,B,C,D | 3BOG | 0.73 | |
DHI | D-HISTIDINE | A,L | 1ZEA | 0.73 | |
GIM | GLUCOIMIDAZOLE | A | 3D4Z | 0.71 | |
GIM | GLUCOIMIDAZOLE | A,B | 2CEQ | 0.71 | |
GIM | GLUCOIMIDAZOLE | A,B | 2CES | 0.71 | |
HIQ | 1-[1,2-DIHYDROXY-1-(HYDROXYMETHYL)ETHYL]- L-HISTIDINE | A,B | 2IU4 | 0.76 | |
GI1 | METHOXYCARBONYL-SUBSTITUTED GLUCOIMIDAZOLE | A,B | 2J7D | 0.76 | |
XXY | 2-[(1R,2R)-1-amino-2-hydroxypropyl]- 1-(carboxymethyl)-4-(1H-imidazol- 5-ylmethyl)-1H-imidazol-5-olate | A | 2FWQ | 0.78 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | T | 2P8Z | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | T | 2P8Y | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,B,C,D,E,F | 2ZIT | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,C,E | 1ZM3 | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A | 1U2R | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,B,C,D,E,F | 1ZM9 | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,B,C,D,E,F | 3B78 | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,B,C,D,E,F | 3B8H | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | T | 2P8X | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,B,C,D,E,F | 3B82 | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,B,C,D,E,F | 1ZM4 | 0.75 | |
DDE | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)- 1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}- TRIMETHYL-AMMONIUM | A,C,E | 1ZM2 | 0.75 | |
NEU | L-NEOPTERIN | A | 2O90 | 0.73 | |
NEU | L-NEOPTERIN | A,B,C,D | 2NM2 | 0.73 | |
HS8 | 3-(1-sulfo-1H-imidazol-3-ium-4- yl)-L-alanine | A,B | 3ETS | 0.71 | |
HS8 | 3-(1-sulfo-1H-imidazol-3-ium-4- yl)-L-alanine | A,B | 3ETT | 0.71 | |
GI2 | METHYL ACETATE-SUBSTITUTED GLUCOIMIDAZOLE | A,B | 2J7E | 0.79 | |
HIP | ND1-PHOSPHONOHISTIDINE | A,B,C,D,E,F | 2VME | 0.71 | |
HIP | ND1-PHOSPHONOHISTIDINE | A | 1NSP | 0.71 | |
HIP | ND1-PHOSPHONOHISTIDINE | A,B,C | 1NSQ | 0.71 | |
HIP | ND1-PHOSPHONOHISTIDINE | A | 1PFH | 0.71 | |
HIP | ND1-PHOSPHONOHISTIDINE | A | 1JEM | 0.71 | |
HRB | N-ACETYL-1-[(2R,3S,5R)-5-HYDROXY- 2-PENTYLTETRAHYDROFURAN-3-YL]-L- HISTIDINE | H,L | 2DDQ | 0.71 | |
BIO | BIOPTERIN | A | 1SEP | 0.71 | |
BIO | BIOPTERIN | A,B | 2A0S | 0.71 | |
BIO | BIOPTERIN | A,B,C | 1Y13 | 0.71 | |
BIO | BIOPTERIN | A,B | 1B66 | 0.71 | |
BIO | BIOPTERIN | A,B,C,D | 2BD0 | 0.71 | |
PVH | HISTIDINE-METHYL-ESTER | B,D,F | 1IBV | 0.71 | |
PVH | HISTIDINE-METHYL-ESTER | B,D,F | 1IBW | 0.71 | |
MPU | D-MONAPTERIN | A | 2NM3 | 0.73 | |
NEO | NEOPTERIN | A | 1BR5 | 0.73 | |
GIR | GIRODAZOLE | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 2OTL | 0.75 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 2EMN | 0.71 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 1EMF | 0.71 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 2EMD | 0.71 | |
CSH | [2-(2-HYDROXY-1-METHYL-ETHYL)-4- (1H-IMIDAZOL-4-YLMETHYL)-5-OXO- IMIDAZOLIDIN-1-YL]-ACETIC ACID | A | 2EMO | 0.71 | |
GI3 | CARBOXYLATE-SUBSTITUTED GLUCOIMIDAZOLE | A,B | 2J7F | 0.78 | |
MVL | (5R,6R,7S,8R)-6,7,8-trihydroxy- 5-(hydroxymethyl)-5,6,7,8-tetrahydro- 1H-imidazo[1,2-a]pyridin-4-ium | A | 3D4Y | 0.71 | |
MVL | (5R,6R,7S,8R)-6,7,8-trihydroxy- 5-(hydroxymethyl)-5,6,7,8-tetrahydro- 1H-imidazo[1,2-a]pyridin-4-ium | A,B | 2VMF | 0.71 | |
BDH | L-BETA-ASPARTYLHISTIDINE | A,B | 1YBQ | 0.73 | |
HSA | PHOSPHORIC ACID MONO-[2-AMINO-3- (3H-IMIDAZOL-4-YL)-PROPYL]ESTER | A | 1GEX | 0.73 | |
HSA | PHOSPHORIC ACID MONO-[2-AMINO-3- (3H-IMIDAZOL-4-YL)-PROPYL]ESTER | A,B,C,D | 1UU1 | 0.73 | |
HSA | PHOSPHORIC ACID MONO-[2-AMINO-3- (3H-IMIDAZOL-4-YL)-PROPYL]ESTER | A | 1FG3 | 0.73 |